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In this summary of therapy for severe asthma
there is no mention of etiologic factors. The author
presumes that if infection is the primary factor in
the progression to severe asthma that this will
be recognized and appropriately treated. A chest
x-ray must be an initial laboratory study for the
recognition of pneumonia or complicating pneumothorax. However, unlike respiratory failure due
to emphysema, here the specific therapy of the
altered pulmonary physiology is of paramount
importance. Attention to the inciting factors is of
minimal therapeutic benefit once infection can be
ruled out. After the patient can breathe comfortably again the role of allergy can be investigated.
Premature investigation of emotional factors can
be a lethal therapeutic error in the ill asthmatic.
The treatment of asthma at the University of
Virginia Hospital can be divided into three rather
specific periods (Table 1).
Mystery Period. Until 1962 arterial blood
gas and pH measurement were not routinely available as a clinical tool in our laboratories. Most patients with severe asthma did well with our routine management. Other patients who looked the
same might die suddenly with no major change in
their clinical course. The mystery revolved around
our inability to judge precisely who had life
threatening asthma and who did not.
Measurement and Aggression 1962-1968.
(Table 2). As soon as arterial puncture became a
routine procedure the mystery cleared somewhat.
Many patients with severe asthma were found to
our surprise to have severe hypoxemia and hypercarbia. It is presumed that the prior mystery
deaths were most likely due to respiratory failure
with CO~ narcosis or hypoxemia-induced fatal ar-
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rhythmias. These patients were recognized usually
late in their disease. Immediate tracheostomy was
done; many were hyperventilated with a volume
controlled ventilator into frightening states of
alkalosis, and the hospitalization was prolonged
for two to three weeks. The patients did not die
from asthma, however, and survived their respiratory care (3).
Measurement and Intensive Care. Employing the lessons learned from our middle period,
since 1968 our management of severe asthma has
changed (Table 3) . In the period 1965-1967,
10 patients with severe asthma were ventilated following tracheostomy and all survived. From 1968
to 1971 there were 299 admissions of asthmatics
to the University of Virginia Hospital. Of these
patients, 50 were judged to be in status asthma,
and 36 had a P co, greater than 45 mm Hg. Despite
the serious nature of their disease, only 8 patients were intubated, 6 were briefly ventilated,
and only 1 patient needed a tracheostomy. No
deaths occurred ( 4).
Common Errors in Management. (Table 4).
A review of patients previously reported with tracheostomy and our current series since 1968 revealed the same errors in management with the
difference being one of degree.
Steroids. In the prior series, two patients received no steroids at all prior to tracheostomy. In
our current patient group, several who were intubated received steroids late in their clinical course
and in small amounts.
Sedation. The use of sedation continues to
be an identifiable factor probably responsible for
the deterioration and intubation in at least half of
the patients intubated since I 968. Valium® and
other tranquilizers are replacing the barbiturates as
major offenders. Sedatives have no place in the
management of severe asthma.
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TABLE I.
MANAGEMENT OF SEVERE ASTHMA
University of Virginia Hospital
Mystery Period- Until 1962
Measurement and Aggression 1962- 1968
Measurement and Intensive Care 1968- Present

Oxygen. The indiscriminate use of high flow
oxygen is not as devastating to the asthmatic in
acute respiratory failure as to the patient with
chronic bronchitis and emphysema. An attempt
should be made to keep the arterial oxygen in the
physiologic range (70-110 mm Hg) which generally means the use of no more than 28-35%
oxygen.
Nursing Position. Classically, the patient with
asthma is immediately put flat in bed, and, to
make sure he stays there, intravenous fluids are
begun apparently to facilitate rapid drug administration. Like the patient with emphysema, the
asthmatic is much more comfortable breathing
in a chair. IV fluids should be replaced with oral
medication usually within 24-48 hours except in
unusual circumstances. This can be of immense
psychological benefit as well as prevent painful
phlebitis.
Tracheostomy. From our current experience
and that of others ( 2), tracheostomy should rarely
be necessary in the management of asthma.
The morbidity associated with the procedure itself and the prolongation of hospital care, coupled
with the short clinical course of aggressively treated
asthma, all make nasotracheal tube intubation
the procedure of choice when respiratory failure
supervenes.
Patients at Risk. Who are the patients who are
in the most danger of progression to respiratory failure? The same group (Table 5) appears in every
series.

TABLE 2.
MEASUREMENT AND AGGRESSION 1962- 1968
Arterial Gas Measurements Begun in 1962
Usually Obtained Late in Course
Serious Nature of Disease Recognized
Usually Immediate Tracheostomy
Frequently Hyperventilated
Two to Three Week Hospitalization

TABLE 3.
MEASUREMENT AND INTENSIVE CARE 1968- PRESENT
Arterial Gas Measurement Early in Suspicious Cases
Review of Prior Medication Imperative
Uncomplicated Asthma- Low P 0 ,- Lo1v Pco,
Severe Asthma-Normal Pco, a Grave Prognostic Sign

How to Evaluate Severity of Asthma.
Prior Medications. A patient who is in marked
respiratory distress with asthma, and who has taken
only a few tablets in the prior 24 hours, is in a different prognostic category than the patient with
the same degree of airway obstruction who has
tried Tedral®, aminophylline suppositories, and 20
mg of prednisone two hours before. An assessment of prior therapy then enables you to plan
current therapy and escalate from theophylline,
ephedrine and adrenaline, to high dose steroid
therapy and hopefully avoid respiratory failure
and intubation.
Arterial Blood Gases. The major initial defect
in asthma is hypoxemia, as large areas of the lung
that have excellent perfusion get progressively less
ventilation, shunting poorly oxygenated blood into
the arterial circulation. Initially, the asthmatic in
respiratory distress can easily overventilate the uninvolved areas of the lung lowering arterial C02
(Pac 0 ,). The classical arterial gases of the dyspneic,
but non-fatigued asthmatic, are a low Pa 0 , (5060 mm Hg) and a low Paco, (20-30 mm Hg). As
the patient tires, is sedated, gets worse, and is re·
strained in bed, he will begin to move less air, and
underventilation will begin with the Paco, approaching normal. This is a grave prognostic sign.
If the arterial oxygen rises as the Pco, rises
and the patient is more comfortable, all is well. If
the arterial oxygen falls and the Pco, approaches
normal, you should immediately escalate your therapy (Table 6).

TABLE 4.
COMMON ERRORS IN MANAGEMENT
Too Little Steroids Too Late
Sedation
High Flow Oxygen
Patient Put in Bed
Tracheostomy
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TABLE 5.
PATIENTS AT RISK

Tired
Old
Fat
Chronic Bronchitis and Emphysema
Heart Disease

Escalation of Drug Therapy.
Combination Tablets and lsupre'tJ9. Most patients with asthma who present to the physician
with a severe episode have already tried regular
therapy with one of the phenobarbital, theophylline, or ephedrine combinations such as Tedra!® or
Quadrinal®. They have generally used, and at
times have overused, an Isuprel® preparation.
These drugs then have little place in the management of the severe asthmatic. It is important, however, to obtain specific historical facts about their
use in planning therapy. A patient who has had
little or no prior medication can be expected to
respond more rapidly to less medication.
One investigator has found that patients with
severe asthma are specifically unresponsive to
Isuprel®, so that response to Isuprel® was a measure not only of the severity of the disease, but
also an index of the patient's response to other
therapy, primarily steroids. More and more Isuprel® is then used by the worsening patient with
less and less results. At times the Isuprel'.!ll has
been shown to have been responsible for increasing the asthma and may actually cause hypoxemia.
Epinephrine and Aminophyllin. The response
to 0.3 cc of epinephrine subcutaneously can at
times be magical and should always be tried. The
effect occurs within minutes and may last an
hour. If no results are obtained after three doses

TABLE 6.
BOTH STATES MAY BE AsSOCIATED WITH REDUCTION
IN WHEEZING AND A QUIET PATIENT

Po,-60
Pco,- 30
pH-7.48

P 0 ,-50
->

Pco,- 40
pH- 7.4

!
P 0 , -70

Pco,-40
pH-7.40

REJOICE!

WORRY!

ACT!

repeated at 15 minute intervals, a response will
usually not be obtained. The response to IV aminophyllin may be equally as rapid and last for
hours, frequently as long as six. The dose must
be large-500 mg for an adult-and must be
given over 15-45 minutes, not over hours in a
large bottle of fluids. Two methods are equally
acceptable:
I. 500 mg ( a 20 cc ampule) given intravenously by syringe, over a IO minute
period. This is excellent if you have
the time.
2. 500 mg in 250 cc glucose and water
given by IV drip over a 30-60 minute
period may be equally effective.
Decisions. Only the consultant the next morning has the benefit of the clearly outlined flow
sheet documenting blood gases, clinical state, and
t!me of the therapeutic maneuvers. In actual practtc~, the patient arrives in respiratory distress, arterial gases are obtained, and the above medications are given-epinephrine X2 followed by
500 mg of IV aminophyllin. This takes approximately one or one and one-half hours. The initial blood gases become known to the physician
ab~ut hal_f way through this therapy. He usually
waits until 15-20 minutes after the aminophyllin
is given and repeats the arterial gases and pH.
Initial Gases. If the Paco, is below 50 mm Hg,
supplemental oxygen is begun (24 or 28% ventimask).
If the Pa co, is greater than 40 mm Hg and the patient
has not obtained evident clinical improvement from
?is initial therapy, 250 mg of hydrocortisone is given
mtravenously in addition to the other drugs previously
described.
Second Arterial Gases. These results have
usually been obtained at a time when full therapeutic benefits will have occurred from epinephrine and aminophyllin therapy. A lack of clinical
response by the patient and a lack of significant
reduction in Paco, dictates that aggressive steroid
!herapy should be begun. If the Paco, has dropped
mto the 30 mm Hg range, therapy with aminophyllin
and epinephrine can be continued and a maintenance
drug such as Tedra! ® SA begun at an appropriate
time.
Steroid Therapy.
General Considerations. There is no reason
to give hydrocortisone except for the initial dosage.
There is theoretical evidence that the therapeutic
effect of hydrocortisone should be more rapid
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than prednisolone, but there is little data. I am in
agreement with Sheehy et al. that airway resistance is reduced by steroids "in several hours"
( 4). This has been shown to be true by the studies of Pinkerton and Van Meter (1) .
This brings up the practical consideration that
by the time one decides to escalate to steroid
therapy one must wait one to two hours for therapeutic effect. One must then give steroids one or
two hours before they are needed. This is why
250 mg of hydrocortisone is given if the initial
gases indicate even slight C02 retention instead
of awaiting the second set two hours later. Pinkerton and Van Meter (1) could show little difference in the dose response curves of oral and IV
steroids. However, in a seriously ill patient who
may vomit, the intravenous method is preferable.
Dosage Schedule. As long as the patient is in
respiratory distress and the Paco, is 44 mm Hg
or above, prednisolone 50 mg should be given every
two hours. If the Paco, continues to rise, the dosage
should be increased to I 00 mg every one to two
hours.
Pediatric Dosage. In severe asthma (as defined under "Initial Gases") 7 mg/ kg of hydrocortisone should be given as an initial stat
dose. Another 7 mg/ kg of hydrocortisone may
be given during the next 24 hours in divided
doses. As is true in adults, there is little specific
data to direct prednisone therapy in children
within narrow dosage guidelines.
Mucolytic A gents. Hydration with appropriate
intravenous fluids and aggressive therapy of asthma . are the only two mucolytic techniques of
proven benefit. Glyceryl guacolate (Robitussin®)
is of proven uselessness and acetylcysteine (Mucomyst®) will provoke asthma. Humidified air
can be added to the ventimask if the patient is a
mouth breather, but humidity and heat are usually
no problem as long as the nose is still in the circuit.
Intubation and Ventilation.
Indications for Intubation. A nsmg Paco,
above 60 mm Hg, a pH below 7 .2, increasing fatigue, increasing somnolence with inability to cough
despite the therapy as outlined above are indications for intubation and ventilation.
General Considerations. The use of the cuffed
nasotracheal tube has revolutionized the respiratory care of severe asthma. Only in unusual circumstances should tracheostomy have to be done
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for asthma. Once nasotracheal intubation is accomplished and the patient is being artificially
ventilated, aggressive therapy must be continued.
Unlike the patient with chronic bronchitis and
emphysema, the patient with asthma responds
quickly and fairly predictably to therapy (primarily corticosteroids) and can be weaned from
the ventilator in 24 to 72 hours. The unfortunate
tendency is for the physician to relax following intubation of the patient. Unless the appropriate therapy is continued, weaning from the ventilator can be
prolonged by a relapse which increases the possibility that tracheostomy will need to be done.
Plan of Action. The physician should presume that with appropriate therapy and barring
serious complications, the patient can be extubated
within 48 hours. The first twelve hours that the
patient is on the ventilator should not be complicated by premature weaning procedures. The fatigued patient should be allowed to rest. His ability to cycle with the ventilator should be enhanced with diazepam (Valium®) or if this is not
immediately effective, with 5 to 10 mg of intravenous morphine (given every one to four hours
as neeqed). Obviously the patient cannot be simultaneously sedated for control of ventilation and
weaned from the ventilator, although this is frequently tried with disastrous results. Prednisone
100 mg every two hours should be continued
during this most important phase of therapy.
Choice of Ventilator. The tendency of a nasotracheal tube to leak, coupled with the extremely
high airway pressures (3~0 cm H 20) necessary to
ventilate asthmatics, makes pressure cycled ventilators
(Bird or Bennett) poor choices. A volume controlled
ventilator such as the Bennett MA- I or the Emerson
postoperative ventilator is usually necessary for
effective ventilation of these noncompliant lungs.
The MA-I enables the respiratory care personnel to
easily monitor tidal volumes and oxygen percentage of
inspired air (F1 0 .). Both machines will intermittently
and automatically hyperinflate the patient's lungs to
reduce atelectasis. Both are dependable machines.
Complications. All of the legion of complications incident to intubation and mechanical ventilation of course can occur. The excellent prognosis for return to normal in these patients should
make their recognition and reversal all the more
important. Several complications however are more
peculiar to the asthmatic.
Pneumothorax. In the pediatric patient, the
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extremely high airway pressures needed for ventilation make this a common complication. Insertion
of a chest tube with adequate seal is imperative
to prevent a tension pneumothorax. This is a rare
complication in adults.
Overventilation with Alkalosis. The very nature of the disease makes this complication potentially common and severe. The patient with
severe, reversible airway obstruction is connected
to an efficient ventilator, and aggressive appropriate
therapy is given. Success in therapy will almost
always result in hyperventilation, unless blood
gases are monitored frequently as the patient improves and the minute ventilation reduced.
Cardiovascular Collapse as Mechanical Ventilation is Begun . This is more common in the patient with emphysema since the high airway pressures are transmitted more readily to the heart
through abnormal lung tissue hindering right heart
filling. The asthmatic has some protection due to
the normal lung parenchyma. However, the combination of high inspiratory airway pressures,
hypovolemia, and a short expiration time may
rapidly reduce cardiac output even in the asthmatic. The physician must prolong expiration as much
as possible relative to inspiratory time, reduce
tidal volumes even if C0 2 cannot be lowered initially, and immediately correct the hypovolemic
state.
Weaning. Improvement can be judged by a
return of the Paco , to normal (30-40 mm Hg)
and a reduction in the percentage of oxygen necessary to maintain Pa 0 , within a physiologic range
(70-100 mm Hg). Reduction in airway obstruction
can be monitored by following the "effective compliance" (tidal volume divided by airway pressure
expressed as liters/ cm H 2 0).
If at the end of 12 hours, blood gases and pH
are normal and the effective compliance has
doubled, sedation should be discontinued and the
patient's ventilatory capabilities measured, using
a Wright Respirometer. If it can be determined
that the tidal volume is greater than 5 cc/ kg and
the vital capacity greater than 10 cc/ kg, a period of time off the ventilator should be monitored with blood gas measurements ( arterial
puncture 15-30 minutes off ventilator with patient receiving humidified 28-30% 0 2 by means
of a Briggs T-piece). If the patient is able to
maintain a normal or reduced Paco,, extubation
should be considered. Alternately this procedure
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is repeated every 12 hours or at even shorter intervals depending upon the observed rate of improvement.
Preparing for Discharge. The exciting part
of the therapy is now over, <1nd the tendency toward management errors increases. If the reason
for the onset of the severe episode of asthma is
known and has been corrected (infection, exposure to irritant fumes, resolved psychic trauma)
then the steroid dosage can be quickly reduced
to 100-200 mg of prednisone given as a single
daily dose, then every other day, and finally discharge of the patient on 10 or 20 mg of prednisone every other day. If the cause of the asthma
remains unknown, caution will have to be exercised in the rapid reduction of steroids.
Two major facts should be borne in mind:
1) Even large amounts of prednisone (50-100 mg)
given as a single early morning dose may be
taken by the patient for up to 30 days without
significant adrenal suppression. 2) Alternate day
prednisone therapy, again a single early morning
dose, can be given with little danger of side effects and may be continued for months.
Summary. The successful management of severe asthma involves recognition and aggressive
appropriate therapy, with rapid escalation to steroid therapy as soon as indicated. Intubation with
a nasotracheal tube and ventilation with a volume controlled mechanical ventilator should be an
available option in therapy. Tracheostomy need
rarely be done since most patients can be extubated within 72 hours.
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